
Lupin Limited has informed the Exchange regarding a press release dated April 12, 2024, titled "U.S. FDA Completes Inspection of Lupin s Dabhasa Facility with No Observations.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated April 12, 2024, titled "U.S. FDA Completes Inspection of Lupin s Dabhasa Facility with No Observations.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin